1 minute read
Menopause game changer
Linda Hall
A NEW nonhormonal drug will revolutionise menopause treatments.
The drug, fezolinetant, which acts directly on the brain to prevent hot flushes, was licensed in the US earlier this month and could be prescribed in the UK by the end of this year.
Made by Astellas Pharma, the medication could transform the misery that hot flushes cause for hundreds of thousands of women who are unable or do not want to use hormone replacement drugs (HRT).
“This is a completely blockbuster drug,” declared Prof Waljit Dhillo, an en docrinologist at Imperial College London who headed 2017 trials which opened the door for developing the drug.
SEVERAL UK cancer charities want to see VAT removed from sunscreen.
This is classed as a cosmetic product, incurring a 20 per cent tax which adds an average £1.50 (€1.72) to the cost.
Highfactor sunscreen should be free of VAT, the charities said. The cost of living crisis meant there are items which people now think twice about buying, and a survey by Melanoma Fo
